# "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-

> **NCT02028234** · PHASE4 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 150 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Pantoprazole,
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT02028234
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2015-03
- **Final completion:** 2016-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2014-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02028234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02028234, ""Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02028234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*